Rankings
Pricing
Log In
Free Trial
US-listed companies
Verve Therapeutics, Inc.
Verve Therapeutics, Inc.
VERV
Market cap
$342.99M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2021
Dec 31,
2022
Collaborations revenue
-
2
Research and development
68
130
General and administrative
19
38
Total operating expenses
87
168
Loss from operations
-87
-166
Change in fair value of antidilution rights liability
26
-
Change in fair value of success payment liability
8
-1
Interest and other income, net
0
7
Total other expense, net
-33
8
Loss before provision for income taxes
-
-157
Provision for income taxes
-
0
Net loss
-120
-157
Earnings Per Share, Basic
-
-2.91
Earnings Per Share, Diluted
-
-2.91
Net loss
-120
-157
Unrealized loss on marketable securities
-0
-0
Comprehensive loss
-121
-158